← Back to Clinical Trials
Recruiting NCT01958762

NCT01958762 Screening for Cancers in the Oral CAvity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01958762
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire, Amiens
Condition Oral Cavity Cancer
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2013-10
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Invitation for oral cavity cancer screening

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2013-10 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In the Somme region of France, cancer registry data showed an increasing incidence of oral cancer. The Incidence Rates in Somme as compared to the national rates for Lip, Oral Cavity and Pharynx Cancer were in 2010: 31,4/100 000 Standard population versus 18,2 /100 000 for male and 8,2/100 000 versus 5,5/100 000 for female, disaster area where action to improve early detection for smokers will be assessed. This target population consults late (as 70% of oral cavity cancers are diagnosed at a late stage (T3 or T4). This project is an innovative incentive strategy for screening among general practitioners based on unusual information vectors (tobacconist, local media). The main objective of this study is a screening of oral cavity cancers in tobacco users aged 30-75 years in the Somme region of France.

Eligibility Criteria

Inclusion Criteria: * Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme * lives in somme departement Exclusion Criteria: \-

Contact & Investigator

Central Contact

Bernard DEVAUCHELLE, MD, phD

✉ devauchelle.bernard@chu-amiens.fr

📞 033 3 22 66 83 25

Principal Investigator

Bernard DEVAUCHELLE, MD, phD

PRINCIPAL INVESTIGATOR

Amiens University Hospital

Frequently Asked Questions

Who can join the NCT01958762 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Oral Cavity Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01958762 currently recruiting?

Yes, NCT01958762 is actively recruiting participants. Contact the research team at devauchelle.bernard@chu-amiens.fr for enrollment information.

Where is the NCT01958762 trial being conducted?

This trial is being conducted at Amiens, France, Amiens, France.

Who is sponsoring the NCT01958762 clinical trial?

NCT01958762 is sponsored by Centre Hospitalier Universitaire, Amiens. The principal investigator is Bernard DEVAUCHELLE, MD, phD at Amiens University Hospital. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology